Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Antibody Drug Conjugates Market Research Report 2017

  • QYR1649671
  • 112 Pages
  • September 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the global Antibody Drug Conjugates market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antibody Drug Conjugates in these regions, from 2012 to 2022 (forecast), covering

North America

Europe

China

Japan

Southeast Asia

India

Global Antibody Drug Conjugates market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

F.Hoffman-La Roche

Novartis

Takeda Pharmaceutial

Pfizer

Seattle Genetics

Genentech

Immunogen

Immunomedics

Progenics Pharmaceutical

Bayer Healthcare Pharmaceutical

Agensys

Concortis Biotherapeutics

Sanofi

Celldex Therapeutics

Synthon Holding

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Adcetris

Kadcyla

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Antibody Drug Conjugates for each application, including

Breast Cancer

Lymphoma

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Antibody Drug Conjugates Market Research Report 2017

1 Antibody Drug Conjugates Market Overview

1.1 Product Overview and Scope of Antibody Drug Conjugates

1.2 Antibody Drug Conjugates Segment by Type (Product Category)

1.2.1 Global Antibody Drug Conjugates Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)

1.2.2 Global Antibody Drug Conjugates Production Market Share by Type (Product Category) in 2016

1.2.3 Adcetris

1.2.4 Kadcyla

1.3 Global Antibody Drug Conjugates Segment by Application

1.3.1 Antibody Drug Conjugates Consumption (Sales) Comparison by Application (2012-2022)

1.3.2 Breast Cancer

1.3.3 Lymphoma

1.4 Global Antibody Drug Conjugates Market by Region (2012-2022)

1.4.1 Global Antibody Drug Conjugates Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)

1.4.2 North America Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 China Status and Prospect (2012-2022)

1.4.5 Japan Status and Prospect (2012-2022)

1.4.6 Southeast Asia Status and Prospect (2012-2022)

1.4.7 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value) of Antibody Drug Conjugates (2012-2022)

1.5.1 Global Antibody Drug Conjugates Revenue Status and Outlook (2012-2022)

1.5.2 Global Antibody Drug Conjugates Capacity, Production Status and Outlook (2012-2022)

2 Global Antibody Drug Conjugates Market Competition by Manufacturers

2.1 Global Antibody Drug Conjugates Capacity, Production and Share by Manufacturers (2012-2017)

2.1.1 Global Antibody Drug Conjugates Capacity and Share by Manufacturers (2012-2017)

2.1.2 Global Antibody Drug Conjugates Production and Share by Manufacturers (2012-2017)

2.2 Global Antibody Drug Conjugates Revenue and Share by Manufacturers (2012-2017)

2.3 Global Antibody Drug Conjugates Average Price by Manufacturers (2012-2017)

2.4 Manufacturers Antibody Drug Conjugates Manufacturing Base Distribution, Sales Area and Product Type

2.5 Antibody Drug Conjugates Market Competitive Situation and Trends

2.5.1 Antibody Drug Conjugates Market Concentration Rate

2.5.2 Antibody Drug Conjugates Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Antibody Drug Conjugates Capacity, Production, Revenue (Value) by Region (2012-2017)

3.1 Global Antibody Drug Conjugates Capacity and Market Share by Region (2012-2017)

3.2 Global Antibody Drug Conjugates Production and Market Share by Region (2012-2017)

3.3 Global Antibody Drug Conjugates Revenue (Value) and Market Share by Region (2012-2017)

3.4 Global Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.5 North America Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.6 Europe Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.7 China Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.8 Japan Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.9 Southeast Asia Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.10 India Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Antibody Drug Conjugates Supply (Production), Consumption, Export, Import by Region (2012-2017)

4.1 Global Antibody Drug Conjugates Consumption by Region (2012-2017)

4.2 North America Antibody Drug Conjugates Production, Consumption, Export, Import (2012-2017)

4.3 Europe Antibody Drug Conjugates Production, Consumption, Export, Import (2012-2017)

4.4 China Antibody Drug Conjugates Production, Consumption, Export, Import (2012-2017)

4.5 Japan Antibody Drug Conjugates Production, Consumption, Export, Import (2012-2017)

4.6 Southeast Asia Antibody Drug Conjugates Production, Consumption, Export, Import (2012-2017)

4.7 India Antibody Drug Conjugates Production, Consumption, Export, Import (2012-2017)

5 Global Antibody Drug Conjugates Production, Revenue (Value), Price Trend by Type

5.1 Global Antibody Drug Conjugates Production and Market Share by Type (2012-2017)

5.2 Global Antibody Drug Conjugates Revenue and Market Share by Type (2012-2017)

5.3 Global Antibody Drug Conjugates Price by Type (2012-2017)

5.4 Global Antibody Drug Conjugates Production Growth by Type (2012-2017)

6 Global Antibody Drug Conjugates Market Analysis by Application

6.1 Global Antibody Drug Conjugates Consumption and Market Share by Application (2012-2017)

6.2 Global Antibody Drug Conjugates Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Antibody Drug Conjugates Manufacturers Profiles/Analysis

7.1 F.Hoffman-La Roche

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Antibody Drug Conjugates Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 F.Hoffman-La Roche Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.1.4 Main Business/Business Overview

7.2 Novartis

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Antibody Drug Conjugates Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 Novartis Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.2.4 Main Business/Business Overview

7.3 Takeda Pharmaceutial

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Antibody Drug Conjugates Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Takeda Pharmaceutial Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.3.4 Main Business/Business Overview

7.4 Pfizer

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 Antibody Drug Conjugates Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Pfizer Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.4.4 Main Business/Business Overview

7.5 Seattle Genetics

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 Antibody Drug Conjugates Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Seattle Genetics Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.5.4 Main Business/Business Overview

7.6 Genentech

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 Antibody Drug Conjugates Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 Genentech Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.6.4 Main Business/Business Overview

7.7 Immunogen

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 Antibody Drug Conjugates Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 Immunogen Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.7.4 Main Business/Business Overview

7.8 Immunomedics

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 Antibody Drug Conjugates Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 Immunomedics Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.8.4 Main Business/Business Overview

7.9 Progenics Pharmaceutical

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 Antibody Drug Conjugates Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Progenics Pharmaceutical Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.9.4 Main Business/Business Overview

7.10 Bayer Healthcare Pharmaceutical

7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.10.2 Antibody Drug Conjugates Product Category, Application and Specification

7.10.2.1 Product A

7.10.2.2 Product B

7.10.3 Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.10.4 Main Business/Business Overview

7.11 Agensys

7.12 Concortis Biotherapeutics

7.13 Sanofi

7.14 Celldex Therapeutics

7.15 Synthon Holding

8 Antibody Drug Conjugates Manufacturing Cost Analysis

8.1 Antibody Drug Conjugates Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Antibody Drug Conjugates

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Antibody Drug Conjugates Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Antibody Drug Conjugates Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Antibody Drug Conjugates Market Forecast (2017-2022)

12.1 Global Antibody Drug Conjugates Capacity, Production, Revenue Forecast (2017-2022)

12.1.1 Global Antibody Drug Conjugates Capacity, Production and Growth Rate Forecast (2017-2022)

12.1.2 Global Antibody Drug Conjugates Revenue and Growth Rate Forecast (2017-2022)

12.1.3 Global Antibody Drug Conjugates Price and Trend Forecast (2017-2022)

12.2 Global Antibody Drug Conjugates Production, Consumption , Import and Export Forecast by Region (2017-2022)

12.2.1 North America Antibody Drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.2 Europe Antibody Drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.3 China Antibody Drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.4 Japan Antibody Drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.5 Southeast Asia Antibody Drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.6 India Antibody Drug Conjugates Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.3 Global Antibody Drug Conjugates Production, Revenue and Price Forecast by Type (2017-2022)

12.4 Global Antibody Drug Conjugates Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

List of Tables and Figures

Figure Picture of Antibody Drug Conjugates

Figure Global Antibody Drug Conjugates Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)

Figure Global Antibody Drug Conjugates Production Market Share by Types (Product Category) in 2016

Figure Product Picture of Adcetris

Table Major Manufacturers of Adcetris

Figure Product Picture of Kadcyla

Table Major Manufacturers of Kadcyla

Figure Global Antibody Drug Conjugates Consumption (K Units) by Applications (2012-2022)

Figure Global Antibody Drug Conjugates Consumption Market Share by Applications in 2016

Figure Breast Cancer Examples

Table Key Downstream Customer in Breast Cancer

Figure Lymphoma Examples

Table Key Downstream Customer in Lymphoma

Figure Global Antibody Drug Conjugates Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)

Figure North America Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Antibody Drug Conjugates Revenue (Million USD) Status and Outlook (2012-2022)

Figure Global Antibody Drug Conjugates Capacity, Production (K Units) Status and Outlook (2012-2022)

Figure Global Antibody Drug Conjugates Major Players Product Capacity (K Units) (2012-2017)

Table Global Antibody Drug Conjugates Capacity (K Units) of Key Manufacturers (2012-2017)

Table Global Antibody Drug Conjugates Capacity Market Share of Key Manufacturers (2012-2017)

Figure Global Antibody Drug Conjugates Capacity (K Units) of Key Manufacturers in 2016

Figure Global Antibody Drug Conjugates Capacity (K Units) of Key Manufacturers in 2017

Figure Global Antibody Drug Conjugates Major Players Product Production (K Units) (2012-2017)

Table Global Antibody Drug Conjugates Production (K Units) of Key Manufacturers (2012-2017)

Table Global Antibody Drug Conjugates Production Share by Manufacturers (2012-2017)

Figure 2016 Antibody Drug Conjugates Production Share by Manufacturers

Figure 2017 Antibody Drug Conjugates Production Share by Manufacturers

Figure Global Antibody Drug Conjugates Major Players Product Revenue (Million USD) (2012-2017)

Table Global Antibody Drug Conjugates Revenue (Million USD) by Manufacturers (2012-2017)

Table Global Antibody Drug Conjugates Revenue Share by Manufacturers (2012-2017)

Table 2016 Global Antibody Drug Conjugates Revenue Share by Manufacturers

Table 2017 Global Antibody Drug Conjugates Revenue Share by Manufacturers

Table Global Market Antibody Drug Conjugates Average Price (USD/Unit) of Key Manufacturers (2012-2017)

Figure Global Market Antibody Drug Conjugates Average Price (USD/Unit) of Key Manufacturers in 2016

Table Manufacturers Antibody Drug Conjugates Manufacturing Base Distribution and Sales Area

Table Manufacturers Antibody Drug Conjugates Product Category

Figure Antibody Drug Conjugates Market Share of Top 3 Manufacturers

Figure Antibody Drug Conjugates Market Share of Top 5 Manufacturers

Table Global Antibody Drug Conjugates Capacity (K Units) by Region (2012-2017)

Figure Global Antibody Drug Conjugates Capacity Market Share by Region (2012-2017)

Figure Global Antibody Drug Conjugates Capacity Market Share by Region (2012-2017)

Figure 2016 Global Antibody Drug Conjugates Capacity Market Share by Region

Table Global Antibody Drug Conjugates Production by Region (2012-2017)

Figure Global Antibody Drug Conjugates Production (K Units) by Region (2012-2017)

Figure Global Antibody Drug Conjugates Production Market Share by Region (2012-2017)

Figure 2016 Global Antibody Drug Conjugates Production Market Share by Region

Table Global Antibody Drug Conjugates Revenue (Million USD) by Region (2012-2017)

Table Global Antibody Drug Conjugates Revenue Market Share by Region (2012-2017)

Figure Global Antibody Drug Conjugates Revenue Market Share by Region (2012-2017)

Table 2016 Global Antibody Drug Conjugates Revenue Market Share by Region

Figure Global Antibody Drug Conjugates Capacity, Production (K Units) and Growth Rate (2012-2017)

Table Global Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table North America Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table Europe Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table China Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table Japan Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table Southeast Asia Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table India Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table Global Antibody Drug Conjugates Consumption (K Units) Market by Region (2012-2017)

Table Global Antibody Drug Conjugates Consumption Market Share by Region (2012-2017)

Figure Global Antibody Drug Conjugates Consumption Market Share by Region (2012-2017)

Figure 2016 Global Antibody Drug Conjugates Consumption (K Units) Market Share by Region

Table North America Antibody Drug Conjugates Production, Consumption, Import & Export (K Units) (2012-2017)

Table Europe Antibody Drug Conjugates Production, Consumption, Import & Export (K Units) (2012-2017)

Table China Antibody Drug Conjugates Production, Consumption, Import & Export (K Units) (2012-2017)

Table Japan Antibody Drug Conjugates Production, Consumption, Import & Export (K Units) (2012-2017)

Table Southeast Asia Antibody Drug Conjugates Production, Consumption, Import & Export (K Units) (2012-2017)

Table India Antibody Drug Conjugates Production, Consumption, Import & Export (K Units) (2012-2017)

Table Global Antibody Drug Conjugates Production (K Units) by Type (2012-2017)

Table Global Antibody Drug Conjugates Production Share by Type (2012-2017)

Figure Production Market Share of Antibody Drug Conjugates by Type (2012-2017)

Figure 2016 Production Market Share of Antibody Drug Conjugates by Type

Table Global Antibody Drug Conjugates Revenue (Million USD) by Type (2012-2017)

Table Global Antibody Drug Conjugates Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Antibody Drug Conjugates by Type (2012-2017)

Figure 2016 Revenue Market Share of Antibody Drug Conjugates by Type

Table Global Antibody Drug Conjugates Price (USD/Unit) by Type (2012-2017)

Figure Global Antibody Drug Conjugates Production Growth by Type (2012-2017)

Table Global Antibody Drug Conjugates Consumption (K Units) by Application (2012-2017)

Table Global Antibody Drug Conjugates Consumption Market Share by Application (2012-2017)

Figure Global Antibody Drug Conjugates Consumption Market Share by Applications (2012-2017)

Figure Global Antibody Drug Conjugates Consumption Market Share by Application in 2016

Table Global Antibody Drug Conjugates Consumption Growth Rate by Application (2012-2017)

Figure Global Antibody Drug Conjugates Consumption Growth Rate by Application (2012-2017)

Table F.Hoffman-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table F.Hoffman-La Roche Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure F.Hoffman-La Roche Antibody Drug Conjugates Production Growth Rate (2012-2017)

Figure F.Hoffman-La Roche Antibody Drug Conjugates Production Market Share (2012-2017)

Figure F.Hoffman-La Roche Antibody Drug Conjugates Revenue Market Share (2012-2017)

Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Novartis Antibody Drug Conjugates Production Growth Rate (2012-2017)

Figure Novartis Antibody Drug Conjugates Production Market Share (2012-2017)

Figure Novartis Antibody Drug Conjugates Revenue Market Share (2012-2017)

Table Takeda Pharmaceutial Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Takeda Pharmaceutial Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Takeda Pharmaceutial Antibody Drug Conjugates Production Growth Rate (2012-2017)

Figure Takeda Pharmaceutial Antibody Drug Conjugates Production Market Share (2012-2017)

Figure Takeda Pharmaceutial Antibody Drug Conjugates Revenue Market Share (2012-2017)

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Pfizer Antibody Drug Conjugates Production Growth Rate (2012-2017)

Figure Pfizer Antibody Drug Conjugates Production Market Share (2012-2017)

Figure Pfizer Antibody Drug Conjugates Revenue Market Share (2012-2017)

Table Seattle Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Seattle Genetics Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Seattle Genetics Antibody Drug Conjugates Production Growth Rate (2012-2017)

Figure Seattle Genetics Antibody Drug Conjugates Production Market Share (2012-2017)

Figure Seattle Genetics Antibody Drug Conjugates Revenue Market Share (2012-2017)

Table Genentech Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Genentech Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Genentech Antibody Drug Conjugates Production Growth Rate (2012-2017)

Figure Genentech Antibody Drug Conjugates Production Market Share (2012-2017)

Figure Genentech Antibody Drug Conjugates Revenue Market Share (2012-2017)

Table Immunogen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Immunogen Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Immunogen Antibody Drug Conjugates Production Growth Rate (2012-2017)

Figure Immunogen Antibody Drug Conjugates Production Market Share (2012-2017)

Figure Immunogen Antibody Drug Conjugates Revenue Market Share (2012-2017)

Table Immunomedics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Immunomedics Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Immunomedics Antibody Drug Conjugates Production Growth Rate (2012-2017)

Figure Immunomedics Antibody Drug Conjugates Production Market Share (2012-2017)

Figure Immunomedics Antibody Drug Conjugates Revenue Market Share (2012-2017)

Table Progenics Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Progenics Pharmaceutical Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Progenics Pharmaceutical Antibody Drug Conjugates Production Growth Rate (2012-2017)

Figure Progenics Pharmaceutical Antibody Drug Conjugates Production Market Share (2012-2017)

Figure Progenics Pharmaceutical Antibody Drug Conjugates Revenue Market Share (2012-2017)

Table Bayer Healthcare Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Production Growth Rate (2012-2017)

Figure Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Production Market Share (2012-2017)

Figure Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Revenue Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Antibody Drug Conjugates

Figure Manufacturing Process Analysis of Antibody Drug Conjugates

Figure Antibody Drug Conjugates Industrial Chain Analysis

Table Raw Materials Sources of Antibody Drug Conjugates Major Manufacturers in 2016

Table Major Buyers of Antibody Drug Conjugates

Table Distributors/Traders List

Figure Global Antibody Drug Conjugates Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)

Figure Global Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Antibody Drug Conjugates Price (Million USD) and Trend Forecast (2017-2022)

Table Global Antibody Drug Conjugates Production (K Units) Forecast by Region (2017-2022)

Figure Global Antibody Drug Conjugates Production Market Share Forecast by Region (2017-2022)

Table Global Antibody Drug Conjugates Consumption (K Units) Forecast by Region (2017-2022)

Figure Global Antibody Drug Conjugates Consumption Market Share Forecast by Region (2017-2022)

Figure North America Antibody Drug Conjugates Production (K Units) and Growth Rate Forecast (2017-2022)

Figure North America Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table North America Antibody Drug Conjugates Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure Europe Antibody Drug Conjugates Production (K Units) and Growth Rate Forecast (2017-2022)

Figure Europe Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Europe Antibody Drug Conjugates Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure China Antibody Drug Conjugates Production (K Units) and Growth Rate Forecast (2017-2022)

Figure China Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table China Antibody Drug Conjugates Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure Japan Antibody Drug Conjugates Production (K Units) and Growth Rate Forecast (2017-2022)

Figure Japan Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Japan Antibody Drug Conjugates Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure Southeast Asia Antibody Drug Conjugates Production (K Units) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Southeast Asia Antibody Drug Conjugates Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure India Antibody Drug Conjugates Production (K Units) and Growth Rate Forecast (2017-2022)

Figure India Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table India Antibody Drug Conjugates Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Table Global Antibody Drug Conjugates Production (K Units) Forecast by Type (2017-2022)

Figure Global Antibody Drug Conjugates Production (K Units) Forecast by Type (2017-2022)

Table Global Antibody Drug Conjugates Revenue (Million USD) Forecast by Type (2017-2022)

Figure Global Antibody Drug Conjugates Revenue Market Share Forecast by Type (2017-2022)

Table Global Antibody Drug Conjugates Price Forecast by Type (2017-2022)

Table Global Antibody Drug Conjugates Consumption (K Units) Forecast by Application (2017-2022)

Figure Global Antibody Drug Conjugates Consumption (K Units) Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Source

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370